Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zonghui Hu

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Plos Pathogens|March 8, 2014
Chronic exposure to type-I IFN under lymphopenic conditions alters CD4 T cell homeostasisCecile Le Saout, Rebecca B Hasley, Hiromi Imamichi, et al.
The Journal of Infectious Diseases|May 2, 2013
Prime-boost interval matters: a randomized phase 1 study to identify the minimum interval necessary to observe the H5 DNA influenza vaccine priming effectJulie E Ledgerwood, Kathryn Zephir, Zonghui Hu, et al.
AIDS (London, England)|August 23, 2013
HIV immune activation drives increased Eomes expression in memory CD8 T cells in association with transcriptional downregulation of CD127Rebecca B Hasley, Changwan Hong, Wenqing Li, et al.
The Journal of Infectious Diseases|December 4, 2012
Enhanced effector function of CD8(+) T cells from healthy controls and HIV-infected patients occurs through thrombin activation of protease-activated receptor 1Amanda Hurley, Mindy Smith, Tatiana Karpova, et al.
Blood|July 14, 2020
Glucocorticoid-induced eosinopenia results from CXCR4-dependent bone marrow migrationSo Gun Hong, Noriko Sato, Fanny Legrand, et al.
Contemporary Clinical Trials|August 16, 2015
Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boostJulie E Ledgerwood, Zonghui Hu, Pamela Costner, et al.
AIDS (London, England)|August 9, 2023
Long-term persistence of transcriptionally active 'defective' HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapyKanal Singh, Ven Natarajan, Robin Dewar, et al.
The Journal of Infectious Diseases|September 17, 2014
Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trialUzma N Sarwar, Pamela Costner, Mary E Enama, et al.
The Lancet. Infectious Diseases|October 7, 2011
DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trialsJulie E Ledgerwood, Chih-Jen Wei, Zonghui Hu, et al.
Plos One|April 18, 2015
Phase 1 study of pandemic H1 DNA vaccine in healthy adultsMichelle C Crank, Ingelise J Gordon, Galina V Yamshchikov, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Plos Pathogens|March 8, 2014
Chronic exposure to type-I IFN under lymphopenic conditions alters CD4 T cell homeostasisCecile Le Saout, Rebecca B Hasley, Hiromi Imamichi, et al.
The Journal of Infectious Diseases|May 2, 2013
Prime-boost interval matters: a randomized phase 1 study to identify the minimum interval necessary to observe the H5 DNA influenza vaccine priming effectJulie E Ledgerwood, Kathryn Zephir, Zonghui Hu, et al.
AIDS (London, England)|August 23, 2013
HIV immune activation drives increased Eomes expression in memory CD8 T cells in association with transcriptional downregulation of CD127Rebecca B Hasley, Changwan Hong, Wenqing Li, et al.
The Journal of Infectious Diseases|December 4, 2012
Enhanced effector function of CD8(+) T cells from healthy controls and HIV-infected patients occurs through thrombin activation of protease-activated receptor 1Amanda Hurley, Mindy Smith, Tatiana Karpova, et al.
Blood|July 14, 2020
Glucocorticoid-induced eosinopenia results from CXCR4-dependent bone marrow migrationSo Gun Hong, Noriko Sato, Fanny Legrand, et al.
Contemporary Clinical Trials|August 16, 2015
Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boostJulie E Ledgerwood, Zonghui Hu, Pamela Costner, et al.
AIDS (London, England)|August 9, 2023
Long-term persistence of transcriptionally active 'defective' HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapyKanal Singh, Ven Natarajan, Robin Dewar, et al.
The Journal of Infectious Diseases|September 17, 2014
Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trialUzma N Sarwar, Pamela Costner, Mary E Enama, et al.
The Lancet. Infectious Diseases|October 7, 2011
DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trialsJulie E Ledgerwood, Chih-Jen Wei, Zonghui Hu, et al.
Plos One|April 18, 2015
Phase 1 study of pandemic H1 DNA vaccine in healthy adultsMichelle C Crank, Ingelise J Gordon, Galina V Yamshchikov, et al.
Pageof 8